Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
GLOBETECH PUBLISHING
JIB

Protein Protects Lung Tissues from Influenza Virus

By BiotechDaily International staff writers
Posted on 28 Jan 2014
Image: Lung tissue from cIAP2-deficient mice showing effects on epithelial cells of influenza infection (Photo courtesy of McGill University).
Image: Lung tissue from cIAP2-deficient mice showing effects on epithelial cells of influenza infection (Photo courtesy of McGill University).
Researchers studying how the body responds to influenza infection have found that the protein called "cellular inhibitor of apoptosis protein 2" (cIAP2) protects the lungs against pulmonary tissue necrosis during virus infection to promote host survival.

cIAP2 is a multifunctional protein that regulates not only caspases and apoptosis, but also modulates inflammatory signaling and immunity, mitogenic kinase signaling, and in cancer cells, cell proliferation, cell invasion, and metastasis. It acts as an E3 ubiquitin- protein ligase regulating NF-kappa-B signaling, and regulates both canonical and non-canonical NF-kappa-B signaling. The target proteins for its E3 ubiquitin-protein ligase activity include RIPK1, RIPK2, RIPK3, RIPK4, CASP3, CASP7, CASP8, TRAF1, and BCL10.

In order to study the role of cIAP2 in H1N1type A influenza, investigators at McGill University (Montreal, Canada) genetically engineered a line of mice to lack the gene for this protein.

They reported in the January 15, 2014, issue of the journal Cell Host & Microbe that mice deficient in cIAP2 exhibited increased susceptibility and mortality to influenza A virus infection. The lethality was not due to impaired antiviral immune functions, but rather because of death-receptor-induced programmed necrosis of airway epithelial cells that led to severe bronchiole epithelial degeneration, despite control of viral replication. Drugs that blocked RIPK1 or genetic deletion of RIPK3, both kinases involved in programmed necrosis, rescued cIAP2-deficient mice from influenza-induced lethality. Genetic deletion of the death receptor agonists Fas ligand or TRAIL (tumor necrosis factor-related apoptosis-inducing ligand) also reversed the susceptibility of cIAP2-deficient mice.

These results indicated that lung tissues were protected from the H1N1 influenza virus by cIAP2 inhibition of RIPK3-mediated programmed necrosis rather than through control of the virus by the immune system.

“It is a discovery that offers exciting new avenues for controlling influenza, since until now attempts to target the virus itself have proven challenging, especially in the face of emerging new strains of the virus,” said senior author Dr. Maya Saleh, associate professor of medicine and biochemistry at McGill University. “The results from our study now suggest that one effective way of countering influenza infections may instead be offered by enhancing the body’s resistance to the virus.”

Related Links:

McGill University



comments powered by Disqus

Channels

Drug Discovery

view channel
Image: The European Commission has approved the use of Avastin combined with chemotherapy as a treatment for women with recurrent ovarian cancer (Photo courtesy of Genentech).

Drug for Treatment of Platinum Resistant Recurrent Ovarian Cancer Approved for Use in Europe

For the first time in more than 15 years the European Commission (EC) has approved a new therapeutic option for the most difficult to treat form of ovarian cancer. Ovarian cancer causes more deaths... Read more

Therapeutics

view channel
Image: This type of electronic pacemaker could become obsolete if induction of biological pacemaker cells by gene therapy proves successful (Photo courtesy of Wikimedia Commons).

Gene Therapy Induces Functional Pacemaker Cells in Pig Heart Failure Model

Cardiovascular disease researchers working with a porcine heart failure model have demonstrated the practicality of using gene therapy to replace implanted electronic pacemakers to regulate heartbeat.... Read more

Lab Technologies

view channel
Image: The DrySyn MULTI converts any standard hotplate stirrer into a high performance reaction block (Photo courtesy of Asynt).

New Reaction Vessel Heating System Is Cleaner and Safer

Biotech and other life science researchers can create a safer, cleaner, and more efficient working environment in their laboratories by switching from oil bath-based heating of reaction vessels to a new... Read more

Business

view channel

Global Computational Biology Sector Expected to Reach over USD 4 Billion by 2020

The global market for computational biology is expected to reach USD 4.285 billion by 2020 growing at a compound annual growth rate (CAGR) of 21.1%, according to new market research. Steady surge in the usage and application of computational biology for bioinformatics R&D programs designed for sequencing genomes... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.